$CALC

CalciMedica (CALC) reporting person holds 0 shares after amendment

Jorey Chernett, a reporting person for CalciMedica, has filed an amended Schedule 13G/A, indicating that they no longer beneficially own any shares of the company's common stock as of May 19, 2026. This "exit filing" officially reports 0% ownership of the class. The amendment serves as a routine ownership update, though it does not detail the specifics of how or when the shares were disposed of.

Original reporting
Published May 21, 2026, 4:09 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 21, 2026, 4:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$CALC
Neutral
medium confidence
Mentioned
$CALC
alphai data visualization · based on Stock Titan
Decision brief

The 30-second read

$CALCNeutralLow
01

Why it matters

This insider activity could influence investor perception, potentially causing short-term price adjustments. However, without further context, it remains a routine disclosure.

02

Market read

The news has limited immediate trading impact, primarily relevant to investors monitoring insider activities in biotech firms.

03

What to watch

Lack of detailed disposal information limits interpretation; consider broader company news and market conditions.

Timing: short-term

Background

CalciMedica recently filed an amended Schedule 13G/A indicating that a reporting person has divested all shares, resulting in 0% ownership.

Company-level read

Ticker impact

$CALCNeutralMedium confidence
Context

The recent filing indicates that CalciMedica's reporting person has divested all shares, suggesting a change in insider ownership.

Expected impact

Potential short-term decrease in stock price due to insider selling, but long-term impact remains uncertain without additional context.

Evidence & confidence

The complete disposal of shares by an insider is noteworthy but does not necessarily indicate negative fundamentals; it could be personal financial planning.

Market effects

Limited sector impact; insider share disposal is company-specific.

Minimal regional influence; no broader market implications indicated.

Negligible

Counterpoint

Insider disposal may be routine and unrelated to company prospects; could be personal financial reasons.

Key entities

  • CalciMedica

    A biotech company focused on developing therapies in the life sciences sector.

Related articles

$LMTMedAI 8/10

What is Patriot missile system, why its supplies are down

The article explains the U.S.-made Patriot mobile air defense system and why interceptor missile supplies are down. It cites Raytheon and Lockheed for system details and notes CSIS estimates about 65% of U.S. interceptors were expended Feb to July, leaving under 850. It says the U.S. approved 5,250 interceptors for Gulf states and awarded Lockheed a contract up to $58.6B.

$ETNMed

Eaton Gains on $7-Million Contract

Eaton (NYSE:ETN) said the U.S. Air Force Research Laboratory awarded it a $7 million, 24-month contract to use quantum computing, machine learning, and advanced visualization to improve power grid resilience and protection. The work, with Infleqtion and Penn State, targets detection and response to multiple concurrent physical and cyber threats, addressing NERC N-2 contingency requirements.

$XOMMed

ExxonMobil awards McDermott engineering work for Rovuma LNG

ExxonMobil Moçambique Limitada issued McDermott Energy Solutions (UK) a letter of intent for limited engineering and procurement work on Rovuma LNG Phase 1 midstream development. The award supports planning ahead of a final investment decision expected in 2026. Rovuma LNG targets 12 modular trains totaling 18.6 mtpa, with start-up in 2031. ExxonMobil says the 30-year project could generate about $150B in revenues for Mozambique’s government.

$ESLTMed

Serbia to open joint UAV factory with Elbit in September

Serbia President Aleksandar Vucic said Serbia will open a joint UAV factory with Elbit Systems, with inauguration expected Sept 15-20. Elbit will hold 51% and Serbia’s state arms firm SDPR 49%. The factory relates to a five-year contract covering precision rockets and unmanned systems, plus ISTAR, digitization and upgrades.

$NOCMed

The Pentagon is urging defense contractors to urgently ramp up weapons production – WP

The U.S. Department of Defense, according to The Washington Post, asked defense contractors to submit within 21 days production and delivery schedules for critical systems, citing depleted stockpiles. CSIS estimates cite heavy early use of missiles and falling Patriot and THAAD inventories. The Pentagon is working with Northrop Grumman and Lockheed Martin, including a $58.6B deal to triple PAC-3 output by 2030, pending a stalled $1.15T defense budget.

$LMTMed

Pentagon pushes military contractors to accelerate production amid shortages after war on Iran

The Pentagon ordered US defense contractors to submit within 21 days plans to accelerate production of missiles and interceptors amid shortages after the first month of strikes against Iran. It cited depleted Patriot and THAAD inventories and said framework agreements with Lockheed Martin and Northrop Grumman target PAC-3 and THAAD output. Lockheed Martin received a contract up to $58.6B to triple PAC-3 production by 2030.